PubMed Health⌕ Search

PubMed · 2688679

Quantitative thallium imaging.

Abstract

There has been much recent interest in quantitative interpretation of 201thallium myocardial imaging. Quantitative analysis can be used as an aid in the more accurate interpretation of myocardial scans. Quantitative analysis is essential to extract information about the kinetics of thallium redistribution. This article briefly reviews the mechanism of uptake and redistribution of 201thallium in the heart and the effect of dipyridamole on uptake and redistribution. Several of the algorithms that have been used to quantitate 201thallium distribution and kinetics on planar studies and the value of quantification on diagnostic accuracy are described. Proper utilization of these methods depends upon a complete understanding of the assumption and the limitations of these algorithms.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Charron, J A Parker. 1989. Quantitative thallium imaging.. https://pubmed.health/record/pubmed%3A2688679/quantitative-thallium-imaging

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.

The peroxisome proliferator-activated receptor (PPAR) family of genes plays a major role in metabolic regulation. Unfortunately, the results of two recent, large event trials of PPAR agonists have been mixed. High rates of crossover to statin use confound the interpretation of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, which found a less than expected reduction in coronary and stroke events with fenofibrate. Of concern, nonsignificant increases in coronary and sudden deaths, thrombotic events, and pancreatitis occurred in the fenofibrate group. The PROspective pioglitAzone Clinical Trial In macroVascular Events (PROACTIVE) also found a reduction in coronary and stroke events with pioglitazone compared with placebo in a population with diabetes and cardiovascular disease, but this benefit was counterbalanced by an increase in congestive heart failure as well as symptomatic edema. Further research is needed to determine the role of PPAR agonists in the prevention of cardiovascular disease.

Coronary Disease↗

Depressive symptoms and sex affect completion rates and clinical outcomes in cardiac rehabilitation.

Symptoms of depression are often seen in patients with coronary heart disease. Symptoms appear more commonly in women and are negatively associated with measures of cardiovascular health. Using multiple logistic regression analyses, the authors evaluated the independent effects of depression (as measured by the Beck Depression Inventory [BDI-II]) and sex on cardiac rehabilitation (CR) completion. In addition, in those who completed CR, the authors evaluated whether depressive symptoms and sex affected clinical outcomes. Women as well as participants with enrollment BDI-II scores > or =14 had significantly higher rates of CR noncompletion. Patients with BDI-II scores > or =14 who completed CR achieved significant improvements in lipid profile, body mass index, and exercise capacity regardless of sex. Women and individuals with BDI-II scores > or =14 are at risk for CR noncompletion and should be encouraged to complete CR, because cardiovascular benefits comparable to those seen in men and individuals with low BDI-II scores were achieved when these patients completed the CR program.

Coronary Disease↗